DEAN TAYLOR-REID: Open Payments
NPI 1295123248 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,074 in 84 payments from 7 companies in 2025. Trend: 2023 $1,903 · 2024 $2,520 · 2025 $2,074
Food & beverage: $2,069Education: $5
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 18 | $599 |
| Neurocrine BioSciences, Inc. | 21 | $392 |
| Teva Pharmaceuticals USA, Inc. | 13 | $338 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $336 |
| Alkermes, Inc. | 10 | $189 |
| ABBVIE INC. | 11 | $175 |
| Lundbeck LLC | 3 | $45 |
Products named: FANAPT, INGREZZA, CAPLYTA, ARISTADA, UZEDY, VRAYLAR, HETLIOZ, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
